27-Jun-2011 - The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.
09-Jun-2011 - Portugal-headquartered API manufacturer Hovione has teamed up with Particle Sciences (PSI) to tackle the issue of poor drug solubility.
08-Jun-2011 - Demand for functional excipients will drive growth of the US market over the next few years according to new analysis.
06-Jun-2011 - Pfizer says it is considering a manufacturing-focused partnership with China’s Zhejiang Hisun Pharmaceutical as part of its generic drug business.
31-May-2011 - Watson Pharmaceuticals has bought Greek generics firm Specifar Pharmaceuticals, bringing to an end a busy month of deal making in the non-branded drug sector.
24-May-2011 - Serina Therapeutics has developed a new way of synthesizing polyoxazoline (POZ) polymers for drug delivery applications that, it claims, is free of the drawbacks that have hampered previous production methods.
17-May-2011 - MWV is offering packaging machinery modifications to support pharmaceutical clients switching to preservative-free pumps.
05-May-2011 - Aptuit is manufacturing Phase III materials for Iroko using a nanoformulation technology that produces fast-dissolving particles.
04-May-2011 - Prosonix and Italian partner Sterling have completed the commercialisation of a respiratory active pharmaceutical ingredient (API) using the UK firm’s unique particle engineering technology.
04-Apr-2011 - The pharmaceutical manufacturing sector in Puerto Rico will thrive because of and not in spite of changes to the country’s tax and incentive laws according to the Puerto Rico Industrial...
21-Mar-2011 - Next month the United Nations Conference on Trade and Development (UNCTAD) will organise a meeting to discuss ways of encouraging the production of pharmaceutical in Africa.
17-Mar-2011 - Don’t think of the global regulatory information clampdown as a burden. It’s an opportunity to put your house in order, says Adam Sherlock, MD of ISI Europe.
15-Mar-2011 - US drug giant Pfizer may sell its generics, consumer health and Capsugel units in an effort to slim down and refocus on its core pharmaceutical business according to a number...
01-Mar-2011 - New research has questioned the widely accepted $1.3bn average cost of R&D per new drug, claiming it is an overestimate and an obstacle.
17-Feb-2011 - Pfizer’s Capsugel unit has bought an injection molding technology that, it believes, will expand its capsule filling business into new “high value segments.”
16-Feb-2011 - French drugmaker Sanofi Aventis will buy Genzyme after the firms finally agree a valuation based on manufacturing performance, approvals and sales.
09-Feb-2011 - Novasep and instrAction have partnered to develop improved methods for the production of taxane-based active pharmaceutical ingredients (API) citing growing demand for cancer treatments as key driver.
18-Jan-2011 - US CRO INC Research has bought industry consulting group Avos Life Sciences, citing pharma clients’ need to maximize return on R&D and minimize risk as the key driver.
10-Jan-2011 - Cultural diversity within India underpins differing attitudes to oral dose pharmaceutical packaging and this could impact on prescribing habits.
14-Dec-2010 - Pharma should forget about ‘the next blockbuster drug’ and invest more money creating novel drug delivery systems with emerging developers to enhance product value and efficacy, say researchers.
01-Dec-2010 - Novartis will reduce its US General Medicines sales force by 1,400 employees next year in preparation for impending patent loss for key products.
08-Nov-2010 - Celanese has launched a new controlled-release EVA excipient and says developing enhanced formulations is key to a drugmaker’s competitive edge in today’s pharmaceutical market.
28-Oct-2010 - Drug industry demand for chemical intermediates and development projects has rebounded significantly in the last 12 months according to UK group Endeavour Specialty Chemicals.
20-Oct-2010 - Particle Sciences (PSI) becomes provider of Solumer drug delivery tech in deal with Israeli developer SoluBest.
19-Oct-2010 - Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.